Kolon Life Science Inc. (KOSDAQ:102940)
60,600
-400 (-0.66%)
Apr 29, 2026, 3:30 PM KST
Kolon Life Science Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 798,527 | 667,298 | 285,738 | 293,298 | 312,699 | 493,057 | Upgrade
|
| Market Cap Growth | 131.63% | 133.53% | -2.58% | -6.20% | -36.58% | 48.78% | Upgrade
|
| Enterprise Value | 891,621 | 782,098 | 384,979 | 380,259 | 385,923 | 578,014 | Upgrade
|
| Last Close Price | 61000.00 | 51700.00 | 23000.00 | 25700.00 | 27400.00 | 43250.00 | Upgrade
|
| PE Ratio | 33.44 | 26.73 | - | - | 146.58 | - | Upgrade
|
| Forward PE | - | 30.73 | 30.73 | 30.73 | 30.73 | 30.73 | Upgrade
|
| PS Ratio | 3.82 | 3.19 | 1.77 | 2.35 | 1.94 | 2.98 | Upgrade
|
| PB Ratio | 1.37 | 1.14 | 1.91 | 2.13 | 1.86 | 4.96 | Upgrade
|
| P/TBV Ratio | 1.37 | 1.15 | 1.92 | 2.13 | 1.88 | 5.03 | Upgrade
|
| P/OCF Ratio | 78.22 | 65.36 | - | - | - | - | Upgrade
|
| PEG Ratio | - | 94.42 | 94.42 | 94.42 | 94.42 | 94.42 | Upgrade
|
| EV/Sales Ratio | 4.27 | 3.74 | 2.38 | 3.05 | 2.39 | 3.49 | Upgrade
|
| EV/EBITDA Ratio | 32.62 | 28.61 | - | - | 31.87 | 37.17 | Upgrade
|
| EV/EBIT Ratio | 50.74 | 44.51 | - | - | 146.09 | 136.03 | Upgrade
|
| Debt / Equity Ratio | 0.18 | 0.18 | 0.85 | 0.78 | 0.44 | 0.69 | Upgrade
|
| Debt / EBITDA Ratio | 3.79 | 3.79 | - | - | 6.10 | 4.43 | Upgrade
|
| Net Debt / Equity Ratio | 0.16 | 0.16 | 0.76 | 0.73 | 0.40 | 0.41 | Upgrade
|
| Net Debt / EBITDA Ratio | 3.41 | 3.41 | -8.64 | -6.57 | 5.58 | 2.64 | Upgrade
|
| Net Debt / FCF Ratio | -3.32 | -3.32 | -5.12 | -2.86 | -2.49 | -1.99 | Upgrade
|
| Asset Turnover | 0.31 | 0.31 | 0.44 | 0.40 | 0.59 | 0.69 | Upgrade
|
| Inventory Turnover | 2.98 | 2.98 | 2.53 | 1.65 | 2.18 | 2.89 | Upgrade
|
| Quick Ratio | 0.28 | 0.28 | 0.24 | 0.26 | 0.33 | 0.51 | Upgrade
|
| Current Ratio | 0.64 | 0.64 | 0.50 | 0.82 | 1.01 | 1.03 | Upgrade
|
| Return on Equity (ROE) | 6.81% | 6.81% | -64.87% | -22.00% | 3.01% | -1.75% | Upgrade
|
| Return on Assets (ROA) | 1.65% | 1.65% | -3.79% | -4.83% | 0.60% | 1.10% | Upgrade
|
| Return on Invested Capital (ROIC) | 2.99% | 3.62% | -8.81% | -10.18% | 1.37% | 3.26% | Upgrade
|
| Return on Capital Employed (ROCE) | 2.40% | 2.40% | -10.40% | -13.30% | 1.30% | 3.10% | Upgrade
|
| Earnings Yield | 3.13% | 3.74% | -32.58% | -10.48% | 0.68% | -0.28% | Upgrade
|
| FCF Yield | -3.51% | -4.20% | -7.80% | -11.94% | -8.69% | -4.18% | Upgrade
|
| Buyback Yield / Dilution | -14.58% | -14.58% | -4.65% | 9.69% | -10.85% | - | Upgrade
|
| Total Shareholder Return | -14.58% | -14.58% | -4.65% | 9.69% | -10.85% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.